ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RDHL Redhill Biopharma Ltd

0.5323
-0.0077 (-1.43%)
Feb 23 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Redhill Biopharma Ltd RDHL NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.0077 -1.43% 0.5323 19:15:28
Open Price Low Price High Price Close Price Prev Close
0.54 0.51 0.5459 0.5374 0.54
more quote information »

Recent News

Date Time Source Heading
2/20/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202407:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202407:00PRNUSRedHill's Opaganib Protects Against Radiation-Induced Lung..
2/16/202408:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/16/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/13/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/02/202416:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/01/202410:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/26/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/26/202412:46PRNUSRedHill Biopharma Announces Closing of $8 Million Registered..
1/26/202409:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/26/202409:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/25/202409:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202409:05PRNUSRedHill Biopharma Announces $8 Million Registered Direct..
1/25/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202406:00PRNUSRedHill Announces New USPTO Patent Grant for Talicia® for H...
12/20/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202308:45PRNUSRedHill and U.S. Army Announce Opaganib and RHB-107..
12/12/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202307:00PRNUSRedHill Biopharma Regains Compliance with Nasdaq Minimum Bid..
12/06/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202307:00PRNUSRedHill Announces New, Non-Dilutive External Funding of..
12/01/202316:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202307:00PRNUSRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market..
11/16/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/14/202308:00PRNUSRedHill Biopharma Announces the Transfer of its Listing to..
10/26/202316:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/202316:06EDGAR2Form F-3/A - Registration statement by foreign private..
10/16/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/13/202308:13EDGAR2Form F-3 - Registration statement by foreign private issuers
10/10/202309:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202307:00PRNUSRedHill and U.S. Army Announce Opaganib's Ebola Virus..
9/29/202308:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202316:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202316:15PRNUSRedHill Biopharma Announces Receipt of Nasdaq Notification..
9/18/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/18/202307:00PRNUSRedHill Announces FDA sNDA Approval for Talicia®
9/05/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/202307:00PRNUSRedHill Announces New USPTO Notice of Patent Allowance for..
8/17/202307:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/202307:00PRNUSRedHill Biopharma Provides H1/23 Financial Results and..
8/11/202316:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/09/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202316:05EDGAR2Form F-3 - Registration statement by foreign private issuers
8/01/202307:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202307:00PRNUSRedHill Biopharma Announces Talicia Approved in the United..

Your Recent History

Delayed Upgrade Clock